THERAPEUTIC OPTIONS FOR ESOPHAGEAL CANCER
Vinay Sharma,
Bernard Donde,
Vinay Sharma
Department of Radiation Oncology, Johannesburg Hospital, University of Witwatersrand, Johannesburg, South Africa
Search for more papers by this authorBernard Donde
Department of Radiation Oncology, Johannesburg Hospital, University of Witwatersrand, Johannesburg, South Africa
Search for more papers by this authorVinay Sharma,
Bernard Donde,
Vinay Sharma
Department of Radiation Oncology, Johannesburg Hospital, University of Witwatersrand, Johannesburg, South Africa
Search for more papers by this authorBernard Donde
Department of Radiation Oncology, Johannesburg Hospital, University of Witwatersrand, Johannesburg, South Africa
Search for more papers by this authorFirst published: 21 May 2009

REFERENCES
- 1 Law S, Wong J. Therapeutic options for esophageal cancer. J. Gastroenterol. Hepatol. 2004; 19: 4–12.
- 2 Sharma V, Agarwal J, Dinshaw KA et al. Late esophageal toxicity using a combination of external beam radiation, intraluminal brachytherapy and 5 Fluorouracil infusion in carcinoma of the esophagus. Dis. Esophagus 2000; 13: 219–25.
- 3 Sur RK, Singh DP, Sharma MT et al. Radiation therapy of esophageal cancer: role of high dose rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1992; 22: 1043–46.
- 4 Hishikawa Y, Kamikonya N, Tanaka S, Miura T. Radiotherapy of esophageal carcinoma: Role of high dose rate intracavitory irradiation. Radiother. Oncol. 1987; 9: 13–20.
- 5 Yin WB. Brachytherapy of carcinoma of the esophagus in China. In: Mould RF, ed. Brachytherapy 2. Leersum: Nucleotron, 1989; 439–41.
- 6 Gasper LE, Nag S, Herskovic A et al. Clinical research committee ABS: American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 1997; 38: 127–32.
- 7 Sharma V, Dinshaw KA, Agarwal JP et al. Intraluminal brachytherapy for palliation of advanced/recurrent carcinoma of the esophagus. J. Brachytherapy Int. 1999; 15: 85–92.
- 8 Sharma V, Mahantshetty U, Dinshaw KA, Deshpande R, Sharma S. Palliation of advanced/recurrent esophageal cancer with high dose rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2002; 52: 310–5.
- 9 Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. A prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—An International Atomic Energy Agency Study. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 127–33.